These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8728291)

  • 1. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis.
    Hamlyn JM; Hamilton BP; Manunta P
    J Hypertens; 1996 Feb; 14(2):151-67. PubMed ID: 8728291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous ouabain, sodium balance and blood pressure.
    Pidgeon GB; Lewis LK; Yandle TG; Richards AM; Nicholls MG
    J Hypertens; 1996 Feb; 14(2):169-71. PubMed ID: 8728292
    [No Abstract]   [Full Text] [Related]  

  • 3. Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.
    Blaustein MP; Hamlyn JM
    Biochim Biophys Acta; 2010 Dec; 1802(12):1219-29. PubMed ID: 20211726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin.
    Manunta P; Hamilton J; Rogowski AC; Hamilton BP; Hamlyn JM
    Hypertens Res; 2000 Sep; 23 Suppl():S77-85. PubMed ID: 11016824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ouabain, digitalis-like factors and hypertension.
    Hamlyn JM; Manunta P
    J Hypertens Suppl; 1992 Dec; 10(7):S99-111. PubMed ID: 1337913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain.
    Hamlyn JM; Lu ZR; Manunta P; Ludens JH; Kimura K; Shah JR; Laredo J; Hamilton JP; Hamilton MJ; Hamilton BP
    Clin Exp Hypertens; 1998; 20(5-6):523-33. PubMed ID: 9682908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure.
    Manunta P; Rogowski AC; Hamilton BP; Hamlyn JM
    J Hypertens; 1994 May; 12(5):549-60. PubMed ID: 7930555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
    Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ouabain-like factors in hypertension: effects of ouabain and certain endogenous ouabain-like factors in hypertension.
    Yuan C; Manunta P; Chen S; Hamlyn JM; Haddy FJ; Pamnani MB
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S10-2. PubMed ID: 7508010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensive effects of the iv administration of picomoles of ouabain.
    Padilha AS; Salaices M; Vassallo DV; Batista PR; Siman FD
    Braz J Med Biol Res; 2011 Sep; 44(9):933-8. PubMed ID: 21956536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium pumps, ouabain and aldosterone in the brain: A neuromodulatory pathway underlying salt-sensitive hypertension and heart failure.
    Leenen FHH; Wang HW; Hamlyn JM
    Cell Calcium; 2020 Mar; 86():102151. PubMed ID: 31954234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat.
    Kimura K; Manunta P; Hamilton BP; Hamlyn JM
    Hypertens Res; 2000 Sep; 23 Suppl():S67-76. PubMed ID: 11016823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring.
    Manunta P; Hamilton BP; Hamlyn JM
    Hypertension; 2001 Feb; 37(2 Pt 2):472-7. PubMed ID: 11230321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men.
    Manunta P; Hamilton BP; Hamlyn JM
    Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R553-9. PubMed ID: 16467503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does salt retention raise blood pressure?
    Blaustein MP; Zhang J; Chen L; Hamilton BP
    Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R514-23. PubMed ID: 16467498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ouabain antagonists as antihypertensive agents.
    Ferrandi M; Barassi P; Molinari I; Torielli L; Tripodi G; Minotti E; Bianchi G; Ferrari P
    Curr Pharm Des; 2005; 11(25):3301-5. PubMed ID: 16250857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
    Rossi G; Manunta P; Hamlyn JM; Pavan E; De Toni R; Semplicini A; Pessina AC
    J Hypertens; 1995 Oct; 13(10):1181-91. PubMed ID: 8586810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous ouabain and the renin-angiotensin-aldosterone system: distinct effects on Na handling and blood pressure in human hypertension.
    Manunta P; Hamlyn JM; Simonini M; Messaggio E; Lanzani C; Bracale M; Argiolas G; Casamassima N; Brioni E; Glorioso N; Bianchi G
    J Hypertens; 2011 Feb; 29(2):349-56. PubMed ID: 20842047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.